Notice
Check the various announcements of oncoMASTER.
2024.02.07 14:45
[oncoMASTER press release] “Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER” (2022. 08. 20. Daily Farm) “Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER” Onmaster has a cancer precision medicine platform... Started by a professor at Korea University School of Medicine Maximizing synergy in R&D with existing partners such as Janssen, Scotec, and Genosco link http://www.dailypharm.com/Users/News/NewsView.html?ID=291060&REFERER=NP Source: Daily Farm (Reporter Seokjun Lee_2022. 08. 20)
ONCOCROSS Co., Ltd.
Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG
Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)
Email: oncocross@oncocross.com
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.